Nanochon closes $4M Series Seed Prime

Contributed by: Business Wire

Logo

Tags

Medical Devices

Surgery

Seniors

Clinical Trials

Other Health

Biotechnology

Physical Therapy

General Health

Consumer

Health

Chondrograft

More Like This

ReLive Biotechnologies Announces NDA Approval of SpheChon 10-70 spheroids/cm² by the HSA in Singapore, Marking a Milestone in ReLive’s Global Endeavors

PR Newswire associated0

ALLOSOURCE ANNOUNCES FIRST PATIENT IMPLANTATION IN UNITED KINGDOM CLINICAL EVALUATION OF PROCHONDRIX CR CRYOPRESERVED OSTEOCHONDRAL ALLOGRAFT

BCV Raises €6M Series A

Promising cooperation between medac and chiron for the development of organ-on chip technology

PR Newswire associated0

Novadip Biosciences SA announces significant clinical milestones for both of its clinical-stage programs

PR Newswire associated0

LifeSpan Vision Ventures Invests in NaNotics

Novotech Appoints Dr. Judith Ng-Cashin as Chief Medical Officer to Drive Global Medical Services

Novotech Executive Team at J.P. Morgan Healthcare Conference: Global CRO Designed for Biotechs Across 25 Regions